Loomis, Sayles & Company
VRNA

Loomis, Sayles & Company’s Verona Pharma VRNA Stock Holding History

Loomis, Sayles & Company’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$59.7M Sell
631,709
-164,581
2025
Q1 		$50.6M Sell
796,290
-283,265
2024
Q4 		$50.1M Sell
1,079,555
-31,541
2024
Q3 		$32M Buy
+1,111,096